Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

naltalimide

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Re: Mechanisms of Inhibitory Action of TRK-130 (Naltalimide), a μ-Opioid Receptor Partial Agonist, on the Micturition Reflex.
  • A. Wein
  • The Journal of urology
  • 2019
    • Corpus ID: 58589895
 
Is this relevant?
2017
2017
Mechanisms of inhibitory action of TRK-130 (Naltalimide), a μ-opioid receptor partial agonist, on the micturition reflex
PurposeTo clarify the mechanism of inhibitory action of TRK-130 (Naltalimide), a unique µ-opioid receptor partial agonist, on the… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2016
2016
Re: Characteristics of TRK-130 (Naltalimide), a Novel Opioid Ligand, as a New Therapeutic Agent for Overactive Bladder.
  • A. Wein
  • The Journal of urology
  • 2016
    • Corpus ID: 808804
available at http://www.ncbi.nlm.nih.gov/pubmed/24928951 Editorial Comment: There are multiple potential mechanisms for… Expand
Is this relevant?
2015
2015
Re: Characteristics of TRK-130 (naltalimide), a novel opioid ligand, as a new therapeutic agent for overactive bladder.
  • A. Atala
  • The Journal of urology
  • 2015
    • Corpus ID: 41727740
 
Is this relevant?
2014
2014
Characteristics of TRK-130 (Naltalimide), a Novel Opioid Ligand, as a New Therapeutic Agent for Overactive Bladder
We characterized TRK-130 (N-[(5R,6R,14S)-17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-yl]phthalimide; naltalimide… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE